MedTrace Logo

Role of Myostatin, Activin A and Follistatin Cachexia of ENT Cancers

NCT03162042 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 60

Last updated 2017-05-22

No results posted yet for this study

Summary

The main objective of our study was to determine the modifications of blood myostatin and activin A concentrations associated with head and neck cancers. Secondary objectives consisted in studying their influence on the occurrence of cachexia, bringing the proof of a tumoral secretion of these factors, and then determining the effect of tumor removal.

Conditions

Interventions

PROCEDURE

Tumor removal

Surgery

Sponsors & Collaborators

  • University Hospital, Clermont-Ferrand

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-11-02
Primary Completion
2016-02-29
Completion
2017-05-31

Countries

  • France

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03162042 on ClinicalTrials.gov